Pharma and biotech M&A activity

Pharma and biotech M&A activity
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about M&A deals in the pharma and biotech industry

This dossier presents key facts and figures about mergers and acquisitions in the pharmaceutical and biotech industry worldwide. For biopharmaceutical companies, M&A deals are often essential for generating growth and acquiring knowledge. This dossier provides a good introduction into the M&A landscape of the industry, including volume, value, and type of deals, as well as an outlook on what trends are expected for 2021.

Table of contents

    • Pharmaceutical market: worldwide revenue 2001-2022

    • Global biotech drug sales 2012-2022

    • Top 10 biotech and pharmaceutical companies based on market cap 2022

    • Top 50 pharmaceutical companies - Rx sales and R&D spending 2021

    • Top pharmaceutical companies by capex growth in 2021

    • Planned and actual healthcare and life sciences activity in 2020, by subsector

    • Global number of life sciences sector deals 2013-2021

    • Number of biopharmaceutical deals worldwide 2016-2020, by type

    • Number of cell and gene therapy deals worldwide 2016-2020, by type

    • Number of biopharma M&A deals worldwide 2010-2019, by companies

    • Number of biopharma M&A deals worldwide 2010-2019, by total transaction value

    • Number of biopharma M&A deals worldwide 2010-2019, by industry

    • Largest M&A pharmaceutical deals ever as of 2023

    • Global value of life sciences sector deals 2013-2021

    • Top completed life sciences deals based on value globally 2020

    • Value of biopharma M&A deals worldwide 2010-2019, by industry

    • Average value of biopharma M&A deals worldwide 2010-2019, by industry

    • Bristol-Myers Squibb's revenue 2006-2022

    • Bristol-Myers Squibb revenue by segment 2015-2020

    • Celgene's revenue and net income 2006-2018

    • Revenue of Celgene 2016-2018, by therapeutic area

    • Top pharma companies worldwide 2022, by size of R&D pipeline

    • Expected acquisitions of biopharma companies by type of asset 2021

    • Expected investment in biopharma and diagnostic lab services 2021, by type

    • Expected valuation changes in healthcare and life sciences 2021, by subsector

    • Expected investment changes in biopharma and diagnostic lab services 2021

Order dossier
More than 7,500
companies trust
Statista

Recommended studies and dossiers

Recent studies and dossiers

You may also be interested in...

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!

Contact
Vayola Jocelyn
Client Support Specialist
support@statista.com +1 212 419-8219

Mon - Fri, 9am - 6pm, EST

Contact (Europe)
Lodovica Biagi
Director of Operations EMEA
eu.support@statista.com +44 (0)20 8189 7000

Mon - Fri, 9:30am - 5pm, GMT

Dossiers, Studies and Reports included in our Business Solutions

Choose one of our Business Solutions to get full access to our international database.

View Business Solutions
No Thanks, order dossier

Statista
Business Solutions

  • Immediate access to dossiers, reports and studies
  • Statistics, outlooks, and forecasts
  • Usage and publication rights

Download your Report

We value your privacy and will never rent or sell your email address.

Privacy

Menu